Dingdang Health repurchases 0.59 million shares for HK$0.63 million; cumulative buy-backs now 42.52 million shares

Bulletin Express04-17 18:45

Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return detailing the latest move under its share-repurchase programme.

Key transaction on 17 April 2026 • Volume: 585,500 ordinary shares • Purchase method: On-market at the Hong Kong Stock Exchange • Price range: HK$1.06 – HK$1.08 per share • Aggregate consideration: HK$0.63 million • All repurchased shares are intended for cancellation.

Capital position • Issued shares (excluding treasury shares) before and after the 17 April transaction: 1.32 billion. • No treasury shares were held at either the opening or closing balance dates.

Cumulative repurchases under current mandate • Period: 25 November 2025 – 17 April 2026 • Total shares bought back but not yet cancelled: 42.52 million, representing 3.22 % of the 1.32 billion shares outstanding when the mandate was approved on 28 May 2025. • Authorised limit: 131.95 million shares, leaving roughly 89.43 million shares (≈6.78 % of issued capital) available for further repurchase within the existing mandate. • The company is restricted from issuing new shares for 30 days following the latest buyback, until 17 May 2026.

Regulatory compliance The board confirmed that all repurchases were executed in accordance with Hong Kong Main Board Listing Rules, with full receipt of funds and satisfaction of relevant legal and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101942867?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 18:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101942867","market":"hk","top_or_hot":-1,"title":"Dingdang Health repurchases 0.59 million shares for HK$0.63 million; cumulative buy-backs now 42.52 million shares","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return detailing the latest move under its share-repurchase programme.</p>\n<p>Key transaction on 17 April 2026  \n• Volume: 585,500 ordinary shares  \n• Purchase method: On-market at the Hong Kong Stock Exchange  \n• Price range: HK$1.06 – HK$1.08 per share  \n• Aggregate consideration: HK$0.63 million  \n• All repurchased shares are intended for cancellation.</p>\n<p>Capital position  \n• Issued shares (excluding treasury shares) before and after the 17 April transaction: 1.32 billion.  \n• No treasury shares were held at either the opening or closing balance dates.</p>\n<p>Cumulative repurchases under current mandate  \n• Period: 25 November 2025 – 17 April 2026  \n• Total shares bought back but not yet cancelled: 42.52 million, representing 3.22 % of the 1.32 billion shares outstanding when the mandate was approved on 28 May 2025.  \n• Authorised limit: 131.95 million shares, leaving roughly 89.43 million shares (≈6.78 % of issued capital) available for further repurchase within the existing mandate.  \n• The company is restricted from issuing new shares for 30 days following the latest buyback, until 17 May 2026.</p>\n<p>Regulatory compliance  \nThe board confirmed that all repurchases were executed in accordance with Hong Kong Main Board Listing Rules, with full receipt of funds and satisfaction of relevant legal and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health repurchases 0.59 million shares for HK$0.63 million; cumulative buy-backs now 42.52 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health repurchases 0.59 million shares for HK$0.63 million; cumulative buy-backs now 42.52 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-17 18:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return detailing the latest move under its share-repurchase programme.</p>\n<p>Key transaction on 17 April 2026  \n• Volume: 585,500 ordinary shares  \n• Purchase method: On-market at the Hong Kong Stock Exchange  \n• Price range: HK$1.06 – HK$1.08 per share  \n• Aggregate consideration: HK$0.63 million  \n• All repurchased shares are intended for cancellation.</p>\n<p>Capital position  \n• Issued shares (excluding treasury shares) before and after the 17 April transaction: 1.32 billion.  \n• No treasury shares were held at either the opening or closing balance dates.</p>\n<p>Cumulative repurchases under current mandate  \n• Period: 25 November 2025 – 17 April 2026  \n• Total shares bought back but not yet cancelled: 42.52 million, representing 3.22 % of the 1.32 billion shares outstanding when the mandate was approved on 28 May 2025.  \n• Authorised limit: 131.95 million shares, leaving roughly 89.43 million shares (≈6.78 % of issued capital) available for further repurchase within the existing mandate.  \n• The company is restricted from issuing new shares for 30 days following the latest buyback, until 17 May 2026.</p>\n<p>Regulatory compliance  \nThe board confirmed that all repurchases were executed in accordance with Hong Kong Main Board Listing Rules, with full receipt of funds and satisfaction of relevant legal and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1101942867","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101942867","pubTimestamp":1776422704,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return detailing the latest move under its share-repurchase programme. Key transaction on 17 April 2026   • Volume: 585,500...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康回购0.59万股，作价0.63万港元；目前累计回购4252万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return detailing the latest move under its share-repurchase programme.\nKey transaction on 17 April 2026  \n• Volume: 585,500 ordinary shares  \n• Purchase method: On-market at the Hong Kong Stock Exchange  \n• Price range: HK$1.06 – HK$1.08 per share  \n• Aggregate consideration: HK$0.63 million  \n• All repurchased shares are intended for cancellation.\nCapital position  \n• Issued shares (excluding treasury shares) before and after the 17 April transaction: 1.32 billion.  \n• No treasury shares were held at either the opening or closing balance dates.\nCumulative repurchases under current mandate  \n• Period: 25 November 2025 – 17 April 2026  \n• Total shares bought back but not yet cancelled: 42.52 million, representing 3.22 % of the 1.32 billion shares outstanding when the mandate was approved on 28 May 2025.  \n• Authorised limit: 131.95 million shares, leaving roughly 89.43 million shares (≈6.78 % of issued capital) available for further repurchase within the existing mandate.  \n• The company is restricted from issuing new shares for 30 days following the latest buyback, until 17 May 2026.\nRegulatory compliance  \nThe board confirmed that all repurchases were executed in accordance with Hong Kong Main Board Listing Rules, with full receipt of funds and satisfaction of relevant legal and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101942867","isCrawlerRequest":true}